Skip to main content
. 2019 Oct 31;38(3):644–654. doi: 10.1016/j.vaccine.2019.10.049

Table 4.

Survival following lethal MPXV challenge.

Study ID Study Group Assignment MPXV Target Challenge Dose (PFU, IV) Survival
Study 1 Controls 5.0E + 07 0/3
ACAM2000 + Placebo 5.0E + 07 6/6
ACAM2000 + Tecovirimat 5.0E + 07 7/7



Study 2 ACAM2000 + Placebo 5.0E + 07 3/3
ACAM2000 + Tecovirimat 5.0E + 07 2/3



Study 3 ACAM2000 + Placebo 5.0E + 07 3/3
ACAM2000 + Tecovirimat 5.0E + 07 3/3